🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
32.59
-0.39 (-1.18%)
At close: Nov 20, 2026, 4:00 PM EST
32.43
-0.16 (-0.49%)
After-hours: Nov 20, 2026, 7:30 PM EST

HRMY Stock Forecast

Stock Price Forecast

According to 12 analysts polled by S&P Global, HRMY stock has a consensus rating of "Buy" and an average price target of $48.08. The average 1-year stock price forecast is 47.53% higher than the current stock price, while the lowest is $32 (-1.81%) and the highest is $70 (+114.79%).

Price Target: $48.08 (+47.53%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$32$48.08$49.5$70
Change-1.81%+47.53%+51.89%+114.79%

Analyst Ratings

The average analyst rating for HRMY stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingJun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Strong Buy445566
Buy222222
Hold433333
Sell111111
Strong Sell000000
Total111011111212

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$20 → $55
BuyReiterates$20 → $55+68.76%Nov 18, 2026
UBS
No rating
UBS
Hold
Maintains
$37 → $39
HoldMaintains$37 → $39+19.67%Nov 6, 2026
Mizuho Securities
Mizuho Securities
Buy
Maintains
$51 → $49
BuyMaintains$51 → $49+50.35%Oct 29, 2026
Needham
Needham
Buy
Reiterates
$50
BuyReiterates$50+53.42%Oct 19, 2026
Ladenburg Thalmann & Co.
Ladenburg Thalmann & Co.
Buy
Initiates
$55
BuyInitiates$55+68.76%Oct 15, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
1.03B
from 868.45M
Increased by 18.31%
Revenue Next Year
1.18B
from 1.03B
Increased by 14.97%
EPS This Year
4.76
from 3.60
Increased by 32.27%
EPS Next Year
6.06
from 4.76
Increased by 27.34%
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026E
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
305.44M437.86M582.02M714.73M868.45M1.03B
Revenue Growth
91.21%43.35%32.93%22.80%21.51%18.31%
Gross Profit
249.92M354.37M460.79M557.92M670.11M762.63M
Gross Margin
81.82%80.93%79.17%78.06%77.16%74.22%
Operating Income
87.53M120.19M192.03M190.83M208.47M269.77M
Net Income
34.60M181.47M128.85M145.49M158.69M223.80M
EPS
----3.604.76
EPS Growth
-----10.89%32.27%
Forward PE
25.2723.0111.1411.8210.056.84
Free Cash Flow
----347.89M230.85M
No. Analysts
-----12
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202620272028
High1.0B
Avg1.0B
Low1.0B

Revenue Growth

Revenue Growth202620272028
High
19.5%
Avg
18.3%
Low
17.2%

EPS Forecast

EPS202620272028
High5.12
Avg4.76
Low4.40

EPS Growth

EPS Growth202620272028
High
42.2%
Avg
32.3%
Low
22.3%